SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is drawing intense community interest due to the potential for regulatory tailwinds and positive sentiment surrounding the psychedelic-assisted therapy sector. Discussions are currently centered on anticipation for upcoming Phase 3 trial data, speculative interest in potential M&A activity, and active debates among traders regarding the company's long-term commercial strategy versus historical governance concerns.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The crow with knife community is actively hyping the token as an essential meme-sector asset, emphasizing its deflationary burn mechanism and multichain presence. Supporters are rallying around the project's grassroots growth and organic cult following, often framing it as a lighthearted yet serious contender in the current meme coin landscape.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is seeing massive volatility and intense community speculation, fueled by a high-profile series of global events and allegations of a pump-and-dump scheme involving concentrated insider holdings. While some investors are betting on the token's utility in real-world event ticketing and short-squeeze potential, others are warning of a significant liquidity trap, leading to heated debates between bullish supporters anticipating further growth and skeptical traders calling for regulatory scrutiny.

Highstreet

Highstreet is actively trending as the community debates its potential for a massive short squeeze following a period of extreme volatility and a sharp price decline. While some traders view the token as a high-conviction recovery play with an oversold chart, others express caution, labeling it a risky asset prone to repeated pump-and-dump cycles.

Daddy Darth Sidious

SIDIOUS is gaining traction within the nano-cap meme coin community as traders speculate on a potential rotation from related tokens like MAULCOIN and DARTH. Participants are actively discussing entry points and the prospect of rapid growth, often framed around the concept of the 'Daddy Darth' thematic wars.

PolySwarm

Polyswarm (NCT) is seeing intense community speculation as investors monitor low float dynamics and potential catalysts, with many hoping that increasing cybersecurity threats will drive adoption and volume. Traders are actively debating the timing of a breakout, with many focusing on technical accumulation patterns while remaining patient for a shift in broader market liquidity.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis is experiencing heightened community interest driven by its integration into the Coinbase #base ecosystem and speculation surrounding a upcoming airdrop. Investors are actively debating the token's potential to compete with major decentralized perp dexes while monitoring volume trends for a breakout toward previous price levels.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is currently in the spotlight as investors await critical Phase 2 data for its anxiety treatment, HLP004, while tracking potential regulatory tailwinds for the broader psychedelic sector. The community remains focused on recent leadership changes and the company's transition to a Nasdaq listing, though sentiment is split between those optimistic about its late-stage MDD pipeline and those expressing frustration over historical volatility and rebranding efforts.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Crypto.com Coin (CRO) is seeing mixed community sentiment as investors weigh persistent concerns about token dilution against potential catalysts like upcoming exchange-linked ETF filings and ongoing integration with AI-focused infrastructure. While many retail holders express frustration over the asset's lagging performance compared to major tokens, others are actively accumulating, pointing to institutional interest and potential regulatory developments as reasons for long-term optimism.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is experiencing massive volume and bullish momentum as the community reacts to reports of a potential executive order regarding federal research into ibogaine for PTSD treatment. While some traders are focused on a high-potential short squeeze setup due to the company's tight float and the sector's broader excitement, others remain cautious of speculative volatility and potential dilution risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The company had initially forecast FY2025 revenue between $8.05 billion and $8.10 billion.</li><li>Preliminary findings suggest that revenue for FY 2023 and 2024 may have been overstated by less than 2%, Icon said.</li><li>Icon plans to release its Q4 and FY2025 earnings results on or prior to April 30, 2026.</li></ul>Shares of Icon Plc (ICLR) fell more than 33% in premarket trading on Thursday after the company withdrew its full-year 2025 guidance and said revenue for 2023 and 2024 may have been overstated.If the premarket level holds after the opening bell, <a href="https://stocktwits.com/symbol/ICLR">ICLR shares</a> would be trading at their lowest levels since May 2017.<h2 class="st-heading-2">Investigation Into Accounting Practices</h2>The company disclosed an ongoing internal investigation by its audit committee, launched in late October 2025, into certain accounting practices and controls, primarily centered on revenue recognition for fiscal years 2023 through 2025.As a result, Icon will not be able to report its 2025 financial results and has subsequently withdrawn its full-year guidance. Preliminary findings also suggest that revenue for FY 2023 and 2024 may have been overstated by less than 2%.<h2 class="st-heading-2">What Guidance Did Icon Withdraw?</h2>The company had earlier forecast FY2025 revenue between $8.05 billion and $8.10 billion and adjusted diluted earnings of $13–$13.20 per share. It also reported revenue of $8.28 billion in FY2024 and $8.12 billion in FY2023.Icon said it intends to release its fourth-quarter (Q4) and FY2025 earnings results on or prior to April 30, 2026.“In response to the current investigation, we are implementing a series of corrective actions to enhance our internal controls over financial reporting,” CEO Barry Balfe said.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the sharp selloff in pre-market, retail sentiment on Stocktwits flipped to ‘ extremely bullish’ from ‘bearish’ a day earlier, amid ‘ extremely high’ message volumes.<figure class="image"><img src="https://news.stocktwits-cdn.com/ICLR_jpg_6e87361557.webp" alt="ICLR.jpg" width="918" height="90"><figcaption>ICLR's Sentiment Meter and Message Volumes at Premarket on Feb. 12, 2026 | Source: Stocktwits</figcaption></figure>One user considered whether to invest in the shares for a “quick turnaround.”<stembedurl>https://stocktwits.com/Wallstfan/message/644772393</stembedurl>Year-to-date, the stock has declined by almost 50%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/soybeans-rally-trump-xi-call-us-china-trade-truce/cZRTlXHR4rO">Trump and Xi’s Two-Hour Call Triggered A Rally In This Commodity - It's Not Gold Or Silver</a> For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stockbroker analyzing financial charts on a computer screen while engaging in a discussion about market trends with a client over the phone, demonstrating expertise in investment strategies. 

ICLR Stock Crashed 33% In Pre-Market Today - Why Did The Company Withdraw Its FY2025 Guidance?

The company disclosed an ongoing internal investigation into certain accounting practices and controls, primarily on revenue recognition for fiscal years 2023 through 2025.

Why Is ICLR Stock Down Today? Icon Flags Accounting Issues, Withdraws FY25 Guidance

Equity

Euro Zone Growth Exceeds Expectations: ETFs in Focus 

EZU slipped 0.6% past month despite stronger-than-expected Eurozone GDP growth and easing trade uncertainty. Growth in Spain, France and Ireland offset declines in Germany and Italy.

Shares of Europe’s largest airline Ryanair Holdings fell nearly 14% during Friday’s pre-market session after the firm reported a 46% year-over-year (YoY) decline in its first quarter profits at €360 million (~$392 million). The airline said that despite a 10% rise in traffic, profit was hit as the key Easter holiday fell in the previous quarter and this quarter’s airfares remained weaker than expected.Even amid the lackluster earnings report, retail investors on Stocktwits remained bullish (57/100) supported by extremely high message volumes.<figure class="image"><img style="aspect-ratio:777/222;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_07_22_at_8_54_34_AM_40f62fb3b4.png" alt="Retail sentiment remains bullish on Ryanair despite lackluster earnings." width="777" height="222"><figcaption>Retail sentiment remains bullish on Ryanair despite lackluster earnings</figcaption></figure>Ryanair said that total revenue declined 1% to €3.63 billion while operating costs increased 11% to €3.26 billion, marginally ahead of traffic growth. Meanwhile, average fare fell by 15% YoY €41.93.The airline expects FY25 traffic to grow 8% from 198 million to 200 million passengers, if Boeing delivery delays do not worsen. Ryanair also believes that while second quarter demand is strong, pricing remains softer than its expectations due to higher domestic capacity. It now anticipates Q2 fares to be materially lower than last summer vs. its earlier expectation of flat to modest gains.On the positive side, the airline is operating its largest ever schedule this summer, with over 200 new routes and five new bases.Ryanair Group CEO Michael O’Leary said In the last 10 days of June, the airline suffered a significant deterioration in European ATC capacity which caused multiple flight delays and cancellations, especially on first wave morning flights. This makes it “more urgent than ever that the new EU Commission and Parliament deliver long delayed reform of Europe’s hopelessly inefficient ATC services,” he said in a statement.Following the disappointing earnings announcement, shares of other European airlines also took a hit. Shares of easy Jet and Wizz Air Holdings fell over 8% on Monday. International Consolidated Airlns Grp, which runs British Airways, also dipped more than 3%.With today’s decline, Ryanair shares are now down more than 20% YTD and over 35% from their all-time highs set in April. Still, retail investors remain bullish on the travel portion of the economy and are betting that shares will regain altitude at some point in the near future.

Ryanair Profits Nearly Halve In June Quarter: But Retail Bets On A Turnaround

The airline said that despite a 10% rise in traffic, profit was hit as airfares remained weaker than expected and Easter fell in the previous quarter. 

The airline said that despite a 10% rise in traffic, profit was hit as airfares remained weaker than expected and Easter fell in the previous quarter. Despite the lackluster earnings, retail investors on Stocktwits remained bullish (57/100) supported by extremely high message volumes.

Current Price	$74.75
Prev Close	$72.86
Open	$74.26
Dividend Yield	N/A
50-Day Moving Average	$71.39
Beta	N/A
Avg. Volume	9,014.85
PE Ratio	N/A

52-Week High	$77.20
52-Week Low	$57.66
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

EIRL
iShares MSCI Ireland ETF

Feed

News

Sentiment

Fundamentals

Info

Latest EIRL News

EIRLiShares MSCI Ireland ETF